Artificial intelligence solutions for temporomandibular joint disorders: Contributions and future potential of ChatGPT
Korean Journal of Orthodontics · 25.03.2025 · 55 (2) · 131-141
DOI: 10.4041/kjod24.106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Korean Journal of Orthodontics, online erschienen am 11.12.2024. Verfasst von Betul Kula und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics, Istanbul Galata University, Istanbul, Türkiye. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthodontics, Istanbul Galata University, Istanbul, Türkiye.
- Department of Prosthodontics, Uskudar University, Istanbul, Türkiye.
- Physical Medicine and Rehabilitation Clinic, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye.
- Department of Physical Medicine and Rehabilitation, Golcuk Necati Celik State Hospital, Kocaeli, Türkiye.
ORCID-Profile: Betul Kula, Ahmet Kula, Fatih Bagcier, Bulent Alyanak
Zitieren
APA
Kula, B., Kula, A., Bagcier, F., & Alyanak, B. (2025). Artificial intelligence solutions for temporomandibular joint disorders: Contributions and future potential of ChatGPT. Korean Journal of Orthodontics, 55(2), 131-141. https://doi.org/10.4041/kjod24.106
Vancouver
Kula B, Kula A, Bagcier F, Alyanak B. Artificial intelligence solutions for temporomandibular joint disorders: Contributions and future potential of ChatGPT. Korean Journal of Orthodontics. 2025;55(2):131-141. doi:10.4041/kjod24.106
BibTeX
@article{Kula2025,
author = {Kula, Betul and Kula, Ahmet and Bagcier, Fatih and Alyanak, Bulent},
title = {Artificial intelligence solutions for temporomandibular joint disorders: Contributions and future potential of ChatGPT},
journal = {Korean Journal of Orthodontics},
year = {2025},
volume = {55},
number = {2},
pages = {131--141},
doi = {10.4041/kjod24.106}
}
EUVIMED